 |
|
Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Hyo Jin Seong, Kwanghyun Lee, Seung Jae Lee, Sangah Kim, Jong Woon Park
Korean J Ophthalmol. 2021;35(3):235-241. Published online 2021 Jun 4 DOI: https://doi.org/10.3341/kjo.2021.0010
|
|
Citations to this article as recorded by
 Association between the use of prostaglandin analogues and ocular surface disease: a systematic review
Raquel Monge-Carmona, Manuel Caro-Magdaleno, María Carmen Sánchez-González
Eye.2025; 39(1): 28. CrossRef Ocular Surface Disease in Glaucoma Patients
Christina Scelfo, Reem H. ElSheikh, Muhammad M. Shamim, Javaneh Abbasian, Alireza Ghaffarieh, Abdelrahman M. Elhusseiny
Current Eye Research.2023; 48(3): 219. CrossRef The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?
Anne Hedengran, Miriam Kolko
Molecular Aspects of Medicine.2023; 93: 101195. CrossRef Initial hypotensive therapy of primary glaucoma with the domestic latanoprost generic: efficacy and safety
S. Yu. Petrov, O. M. Kalinina, L. V. Yakubova, S. M. Kosakyan, L. V. Vasilenkova, O. M. Filippova, A. N. Zhuravleva
Russian Ophthalmological Journal.2022; 14(4): 7. CrossRef Topical glaucoma medications – Clinical implications for the ocular surface
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil, Reiko Arita, Miriam Kolko, Jelle Vehof, Tor P. Utheim
The Ocular Surface.2022; 26: 19. CrossRef Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
Jong-Wook Lee, Hyeon-Soo Ahn, Jinho Chang, Hye-Young Kang, Dong-Jin Chang, Jae Kyung Suh, Hankil Lee
Korean Journal of Ophthalmology.2022; 36(5): 423. CrossRef
|